Advanced gastrointestinal stromal tumor patients with complete response after treatment with imatinib mesylate

AIM: Most gastrointestinal stromal tumors (GISTs) express constitutively activated mutant isoforms of kit kinase or platelet-derived growth factor receptor alpha (PDGFRA), which are potential therapeutic targets for imatinib mesylate (Glivec). Partial response occurred in almost two thirds of GIST p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chiang, Kun-Chun, Chen, Tsung-Wen, Yeh, Chun-Nan, Liu, Feng-Yuan, Lee, Hsiang-Lin, Jan, Yi-Yin
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2006
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4087685/
https://ncbi.nlm.nih.gov/pubmed/16610057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i13.2060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados